Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device
06. März 2018 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, UT, March 06, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company that develops and commercializes silicon nitride as a platform for...
Amedica Submits 510(k) Application to FDA for Valeo C+CSC with Lumen
06. November 2017 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical...